Simplify Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Simplify Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.04M	Buy	+93,521	New	+$2.73M	0.03%	58

Other funds holding COLL

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Kendall Capital Management Rockville, Maryland $605M AUM 38.16% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Verdence Capital Advisors Hunt Valley, Maryland $2.35B AUM 27.25% 1-Year Est. Return

Smith Group Asset Management Dallas, Texas $1.53B AUM 46.79% 1-Year Est. Return

BOK Financial Tulsa, Oklahoma $6.69B AUM 26.84% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Simplify Asset Management's COLL Position: Q3 2026 in Review

Simplify Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 93,521 shares worth $2.04M. The stake represents 0.03% of the portfolio and ranks #58 among its holdings.

41 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

Simplify Asset Management held 93,521 shares of Collegium Pharmaceutical worth $2.04M as of Q3 2026.
Collegium Pharmaceutical was a new Simplify Asset Management position in Q3 2026.
Collegium Pharmaceutical made up 0.03% of Simplify Asset Management's portfolio in Q3 2026, its #58 holding.
41 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Simplify Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.